Huber Reid M
Insider CIK 1607052 · BLCM Director · TNGX Director · CRGX Director · RAPP Director · INCY EVP, Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2026-06-10 | 2026-06-10 | 15,200 | — | $0 | 15,200 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2025-09-12 | 2025-09-15 | 20,400 | $24.48 | $499.4K | 20,400 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | D To issuer deriv | 2025-08-19 | 2025-08-19 | 25,000 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 21,850 | — | $0 | 21,850 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 23,742 | — | $0 | 23,742 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | A Award deriv | 2023-11-09 | 2023-11-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2023-06-06 | 2023-06-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2023-01-03 | 2023-01-05 | 87,196 | — | $0 | 153,179 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2023-01-03 | 2023-01-20 | 80,968 | — | $0 | 146,951 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2022-09-01 | 2022-09-02 | 46,489 | — | $0 | 65,983 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2022-06-15 | 2022-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise deriv | 2022-01-04 | 2022-01-06 | 19,494 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2022-01-04 | 2022-01-06 | 19,494 | — | $0 | 19,494 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2021-06-15 | 2021-07-07 | 6,500 | — | $0 | 6,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2021-01-04 | 2021-01-05 | 19,494 | — | $0 | 19,494 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2020-06-15 | 2020-06-16 | 6,500 | — | $0 | 6,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2019-06-13 | 2019-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2018-07-16 | 2018-07-18 | 448 | $70.19 | $31.4K | 34,571 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2018-07-05 | 2018-07-05 | 284 | $68.28 | $19.4K | 35,019 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2018-07-02 | 2018-07-05 | 22,772 | — | $0 | 22,772 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-06-14 | 2018-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2018-02-21 | 2018-02-22 | 1,958 | $85.55 | $167.5K | 35,183 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2018-02-20 | 2018-02-22 | 1,064 | $86.03 | $91.5K | 37,141 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2018-01-24 | 2018-01-25 | 21,167 | — | $0 | 21,167 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2018-01-23 | 2018-01-25 | 12,128 | — | $0 | 12,128 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-12-01 | 2017-12-05 | 696 | $98.01 | $68.2K | 38,205 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2017-09-13 | 2017-09-15 | 692 | $123.15 | $85.2K | 38,862 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2017-07-05 | 2017-07-07 | 12,128 | — | $0 | 12,128 | SEC↗ |
| INCY INCYTE CORP | A Award | 2017-07-05 | 2017-07-07 | 3,517 | — | $0 | 39,554 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-06-14 | 2017-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-05-08 | 2017-05-09 | 8,577 | $119.21 | $1.02M | 36,037 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2017-05-05 | 2017-05-09 | 7,732 | $125.00 | $966.5K | 44,614 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-02-27 | 2017-03-01 | 2,008 | $131.88 | $264.8K | 52,262 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2017-01-17 | 2017-01-19 | 879 | — | $0 | 879 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2017-01-17 | 2017-01-19 | 17,986 | — | $0 | 17,986 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2017-01-17 | 2017-01-19 | 19,091 | — | $0 | 19,091 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-01-09 | 2017-01-11 | 11,739 | $113.55 | $1.33M | 52,185 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2016-11-09 | 2016-11-10 | 2,715 | $109.95 | $298.5K | 63,924 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2016-10-07 | 2016-10-11 | 11,709 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2016-10-07 | 2016-10-11 | 11,709 | $96.40 | $1.13M | 66,601 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2016-10-07 | 2016-10-11 | 11,709 | $18.32 | $214.5K | 78,310 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2016-08-02 | 2016-08-02 | 10,000 | $87.96 | $879.6K | 66,601 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2016-07-15 | 2016-07-19 | 19,091 | — | $0 | 19,091 | SEC↗ |
| INCY INCYTE CORP | A Award | 2016-07-15 | 2016-07-19 | 5,555 | — | $0 | 76,601 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2016-02-24 | 2017-02-28 | 1,090 | $121.95 | $132.9K | 54,270 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2016-02-16 | 2016-02-18 | 5,377 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2016-02-16 | 2016-02-18 | 5,377 | $18.32 | $98.5K | 71,046 | SEC↗ |
| INCY INCYTE CORP | A Award | 2016-02-14 | 2017-02-28 | 3,098 | — | $0 | 55,360 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2016-01-07 | 2016-01-08 | 18,198 | — | $0 | 18,198 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2016-01-07 | 2016-01-08 | 586 | — | $0 | 586 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2016-01-07 | 2016-01-08 | 21,170 | — | $0 | 21,170 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2016-01-07 | 2016-01-08 | 1,044 | — | $0 | 1,044 | SEC↗ |
| INCY INCYTE CORP | A Award | 2016-01-07 | 2016-01-08 | 2,610 | — | $0 | 65,669 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-09-21 | 2015-09-23 | 10,000 | — | $0 | 11,709 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-09-21 | 2015-09-23 | 10,000 | $124.29 | $1.24M | 62,865 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-09-21 | 2015-09-23 | 10,000 | $18.32 | $183.2K | 72,865 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-08-07 | 2015-08-10 | 2,081 | — | $0 | 5,377 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-08-07 | 2015-08-10 | 6,316 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-08-07 | 2015-08-10 | 6,316 | $17.79 | $112.4K | 60,776 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-08-07 | 2015-08-10 | 2,081 | $18.32 | $38.1K | 62,857 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2015-06-17 | 2015-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-04-16 | 2015-04-17 | 8,030 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-04-16 | 2015-04-17 | 1,355 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-04-16 | 2015-04-17 | 675 | — | $0 | 6,316 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-04-16 | 2015-04-17 | 8,030 | $14.72 | $118.2K | 54,460 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-04-16 | 2015-04-17 | 1,355 | $13.34 | $18.1K | 46,438 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-04-16 | 2015-04-17 | 675 | $17.79 | $12.0K | 45,083 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-03-30 | 2015-04-01 | 17,499 | — | $0 | 21,709 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-03-30 | 2015-04-01 | 16,764 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-03-30 | 2015-04-01 | 10,000 | $93.67 | $936.7K | 68,671 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-03-30 | 2015-04-01 | 17,499 | $18.32 | $320.6K | 61,907 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-03-30 | 2015-04-01 | 16,764 | $17.79 | $298.2K | 78,671 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-03-30 | 2015-04-01 | 5,000 | $93.67 | $468.4K | 48,671 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-03-30 | 2015-04-01 | 7,000 | $93.66 | $655.6K | 53,671 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-03-30 | 2015-04-01 | 8,000 | $93.61 | $748.9K | 60,671 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-03-30 | 2015-04-01 | 4,263 | $93.75 | $399.7K | 44,408 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-01-08 | 2015-01-09 | 20,122 | — | $0 | 20,122 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-01-08 | 2015-01-09 | 1,365 | — | $0 | 1,365 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-01-08 | 2015-01-09 | 1,423 | — | $0 | 1,423 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-01-08 | 2015-01-09 | 28,635 | — | $0 | 28,635 | SEC↗ |
| INCY INCYTE CORP | A Award | 2015-01-08 | 2015-01-09 | 3,022 | — | $0 | 44,562 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-12-02 | 2014-12-03 | 6,494 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-12-02 | 2014-12-03 | 6,494 | $9.41 | $61.1K | 41,386 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-11-12 | 2014-11-14 | 2,900 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-11-12 | 2014-11-14 | 7,835 | — | $0 | 6,494 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-11-12 | 2014-11-14 | 7,225 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-11-12 | 2014-11-14 | 7,225 | $3.11 | $22.5K | 34,892 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-11-12 | 2014-11-14 | 2,900 | $5.46 | $15.8K | 27,667 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-11-12 | 2014-11-14 | 7,835 | $9.41 | $73.7K | 24,767 | SEC↗ |